A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
Clinical trial NCT05953584 · RECRUITING
Trial details
- NCT number
- NCT05953584
- Sponsor
- Forma Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2027-09-20
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.